Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia
Vagner O.C. Rigaud, Clare Zarka, Justin Kurian, Daria Harlamova, Andrea Elia, Nicole Kasatkin, Jaslyn Johnson, Michael Behanan, Lindsay Kraus, Hannah Pepper, Nathaniel W. Snyder, Sadia Mohsin, Steven R. Houser, Mohsin Khan
Vagner O.C. Rigaud, Clare Zarka, Justin Kurian, Daria Harlamova, Andrea Elia, Nicole Kasatkin, Jaslyn Johnson, Michael Behanan, Lindsay Kraus, Hannah Pepper, Nathaniel W. Snyder, Sadia Mohsin, Steven R. Houser, Mohsin Khan
View: Text | PDF
Research Article Cardiology Metabolism

UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia

  • Text
  • PDF
Abstract

Developmental cardiac tissue is regenerative while operating under low oxygen. After birth, ambient oxygen is associated with cardiomyocyte cell cycle exit and regeneration. Likewise, cardiac metabolism undergoes a shift with cardiac maturation. Whether there are common regulators of cardiomyocyte cell cycle linking metabolism to oxygen tension remains unknown. The objective of the study is to determine whether mitochondrial UCP2 is a metabolic oxygen sensor regulating cardiomyocyte cell cycle. Neonatal rat ventricular myocytes (NRVMs) under moderate hypoxia showed increased cell cycle activity and UCP2 expression. NRVMs exhibited a metabolic shift toward glycolysis, reducing citrate synthase, mtDNA, mitochondrial membrane potential (ΔΨm), and DNA damage/oxidative stress, while loss of UCP2 reversed this phenotype. Next, WT and mice from a global UCP2-KO mouse line (UCP2KO) kept under hypoxia for 4 weeks showed significant decline in cardiac function that was more pronounced in UCP2KO animals. Cardiomyocyte cell cycle activity was reduced, while fibrosis and DNA damage was significantly increased in UCP2KO animals compared with WT under hypoxia. Mechanistically, UCP2 increased acetyl-CoA levels and histone acetylation, and it altered chromatin modifiers linking metabolism to cardiomyocyte cell cycle under hypoxia. Here, we show a potentially novel role for mitochondrial UCP2 as an oxygen sensor regulating cardiomyocyte cell cycle activity, acetyl-CoA levels, and histone acetylation in response to moderate hypoxia.

Authors

Vagner O.C. Rigaud, Clare Zarka, Justin Kurian, Daria Harlamova, Andrea Elia, Nicole Kasatkin, Jaslyn Johnson, Michael Behanan, Lindsay Kraus, Hannah Pepper, Nathaniel W. Snyder, Sadia Mohsin, Steven R. Houser, Mohsin Khan

×

Figure 7

Loss of UCP2 alters acetyl-CoA levels and histone marks in cardiomyocytes.

Options: View larger image (or click on image) Download as PowerPoint
Loss of UCP2 alters acetyl-CoA levels and histone marks in cardiomyocyte...
(A and B) Acetyl-CoA levels are significantly increased in NRVMs (A) and adult cardiomyocytes from WT mice (B) under moderate hypoxia and decreased after loss of UCP2 as measured by mass spectrometry–based quantification (n = 3 per group). (C and D) Immunoblot and qPCR validations showing increased levels of enzymes and genes involved in acetyl-CoA signaling and reduced after UCP2 silencing in NRVMs under moderate hypoxia (n = 3). (E) Immunoblot validation showing histone 3 is acetylated in hypoxia and deacetylated after UCP2 silencing in NRVMs. (F) Chart resulting from a qPCR array for 84 chromatin remodeling enzymes indicating the percentage of genes upregulated, downregulated, and unchanged after siRNA-mediated silencing of UCP2 in NRVM after 48 hours of moderate hypoxia (n = 3). (G) Heatmap of the 84 chromatin remodeling enzymes after siRNA-mediated silencing of UCP2 in NRVM under hypoxia. Upregulated, green; downregulated, red (n = 3). (H) Volcano plot highlighting upregulation of histone deacetylation enzymes and downregulation of a histone acetylation enzyme in the qPCR array after UCP2 silencing. Upregulated < fold change 1.5, downregulated > fold change 1.5 (n = 3). (I) Schematic illustration summarizing the findings of this study. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data from A, C, and D were analyzed using Kruskal-Wallis test with Dunn’s correction for multiple comparisons; for B, Mann-Whitney U test was applied.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts